147 related articles for article (PubMed ID: 16025855)
1. Gonadal effect of radiation from 131I in male patients with thyroid carcinoma.
Krassas GE; Pontikides N
Arch Androl; 2005; 51(3):171-5. PubMed ID: 16025855
[TBL] [Abstract][Full Text] [Related]
2. Testicular dose and fertility in men following I(131) therapy for thyroid cancer.
Hyer S; Vini L; O'Connell M; Pratt B; Harmer C
Clin Endocrinol (Oxf); 2002 Jun; 56(6):755-8. PubMed ID: 12072044
[TBL] [Abstract][Full Text] [Related]
3. Impact on testicular function of a single ablative activity of 3.7 GBq radioactive iodine for differentiated thyroid carcinoma.
Bourcigaux N; Rubino C; Berthaud I; Toubert ME; Donadille B; Leenhardt L; Petrot-Keller I; Brailly-Tabard S; Fromigué J; de Vathaire F; Simon T; Siffroi JP; Schlumberger M; Bouchard P; Christin-Maitre S
Hum Reprod; 2018 Aug; 33(8):1408-1416. PubMed ID: 29912343
[TBL] [Abstract][Full Text] [Related]
4. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.
Pacini F; Gasperi M; Fugazzola L; Ceccarelli C; Lippi F; Centoni R; Martino E; Pinchera A
J Nucl Med; 1994 Sep; 35(9):1418-22. PubMed ID: 8071685
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer.
Ceccarelli C; Battisti P; Gasperi M; Fantuzzi E; Pacini F; Gualdrini G; Pierantoni MC; Luciani A; Djokich D; Pinchera A
J Nucl Med; 1999 Oct; 40(10):1716-21. PubMed ID: 10520714
[TBL] [Abstract][Full Text] [Related]
6. Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer.
Handelsman DJ; Turtle JR
Clin Endocrinol (Oxf); 1983 May; 18(5):465-72. PubMed ID: 6409459
[TBL] [Abstract][Full Text] [Related]
7. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
Sarkar SD; Beierwaltes WH; Gill SP; Cowley BJ
J Nucl Med; 1976 Jun; 17(6):460-4. PubMed ID: 944243
[TBL] [Abstract][Full Text] [Related]
8. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer.
Maxon HR; Thomas SR; Hertzberg VS; Kereiakes JG; Chen IW; Sperling MI; Saenger EL
N Engl J Med; 1983 Oct; 309(16):937-41. PubMed ID: 6621620
[TBL] [Abstract][Full Text] [Related]
9. Gonadal damage from 131I therapy for thyroid cancer.
Mazzaferri EL
Clin Endocrinol (Oxf); 2002 Sep; 57(3):313-4. PubMed ID: 12201822
[No Abstract] [Full Text] [Related]
10. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
[TBL] [Abstract][Full Text] [Related]
11. Radioactive iodine (131I) effects on male fertility.
Ceccarelli C; Canale D; Vitti P
Curr Opin Urol; 2008 Nov; 18(6):598-601. PubMed ID: 18832945
[TBL] [Abstract][Full Text] [Related]
12. Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimation.
Jentzen W; Moldovan AS; Ruhlmann M; Görges R; Bockisch A; Rosenbaum-Krumme S
Nuklearmedizin; 2015; 54(3):137-43. PubMed ID: 25987357
[TBL] [Abstract][Full Text] [Related]
13. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
14. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
15. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
Dottorini ME; Lomuscio G; Mazzucchelli L; Vignati A; Colombo L
J Nucl Med; 1995 Jan; 36(1):21-7. PubMed ID: 7799075
[TBL] [Abstract][Full Text] [Related]
16. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
Shimon I; Kneller A; Olchovsky D
Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
[TBL] [Abstract][Full Text] [Related]
18. Cerebral edema following iodine-131 therapy for thyroid carcinoma metastatic to the brain.
Datz FL
J Nucl Med; 1986 May; 27(5):637-40. PubMed ID: 3712081
[TBL] [Abstract][Full Text] [Related]
19. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
Parthasarathy KL; Crawford ES
J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749
[TBL] [Abstract][Full Text] [Related]
20. Testicular function after radioiodine therapy in patients with thyroid cancer.
Rosário PW; Barroso AL; Rezende LL; Padrão EL; Borges MA; Guimarães VC; Purisch S
Thyroid; 2006 Jul; 16(7):667-70. PubMed ID: 16889490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]